June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
The Presence of Calcium Significantly Enhanced Annexin-V-Labelling of Degenerating Axons after Experimental Anterior Ischemic Optic Neuropathy
Author Affiliations & Notes
  • Gun Ho Lee
    Stanford University, Cupertino, CA
  • M Ali Shariati
    Stanford University, Cupertino, CA
  • Ming-Hui Sun
    Stanford University, Cupertino, CA
    Chang Gung Memorial Hospital - LinKou, LinKou, Taiwan
  • Yaping Joyce Liao
    Stanford University, Cupertino, CA
  • Footnotes
    Commercial Relationships Gun Ho Lee, None; M Ali Shariati, None; Ming-Hui Sun, None; Yaping Liao, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5540. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gun Ho Lee, M Ali Shariati, Ming-Hui Sun, Yaping Joyce Liao; The Presence of Calcium Significantly Enhanced Annexin-V-Labelling of Degenerating Axons after Experimental Anterior Ischemic Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5540.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Annexin-V binds to exposed phosphyltidylserine on the extracellular membrane in a calcium-dependent fashion and has been shown to label degenerating retinal ganglion cell axons and soma after experimental anterior ischemic optic neuropathy (AION). Because the labeling of degenerating axons with annexin-V is relatively labile, in this study, we determine whether inclusion of calcium in different experimental steps helps to enhance axonal labeling.

Methods: We induced optic nerve head ischemia in adult C57BL/6 mice using laser-assisted photochemical thrombosis. After one week, we performed intravitreal injection of annexin-V-A488 and imaged the retina 2-3 hours later using confocal scanning laser ophthalmoscopy (cSLO) and optical coherence tomography (OCT). Then, we prepared retinal whole mount in calcium-free or 2.5 mM CaCl2 conditions and imaged the retinae using fluorescence microscopy for up to 7 days after mounting.

Results: On the day of annexin-V-A488 labeling, degenerating axons were easily seen in both Ca2+-containing (N = 30) and Ca2+-free (N = 10) conditions. Annexin-V-A488 labeling of degenerating axons one week after ischemia correlated well with the presence of optic nerve swelling on day-1 as measured by OCT. No annexin-V-A488 labeling of axons was seen in the control eyes (N = 6), which showed no swelling on OCT. Inclusion of Ca2+ to the fixative, wash, and mounting solutions significantly improved the persistence of annexin-V-A488 signal one to seven days after labeling. In contrast to the difficulty of preserving axonal labels, bright annexin-V-A488 signal on degenerating soma was easily seen even one week after labeling. We used these brightly labeled soma to test the lability of annexin-V-A488 labeling over 5, 10, and 20 min of light exposure and found a dramatic, time-dependent decrease in fluorescence signal, consistent with the relative lability of the annexin-V-A488 signal.

Conclusions: Annexin-V-A488 brightly labels degenerating retinal ganglion cell axons one week after experimental anterior ischemic optic neuropathy, and the presence of 2.5 mM Ca2+ during retinal tissue preparation helps preserve this relatively labile label. During microscopy, even minutes of bright light exposure can quench annexin-V-A488 signal, and every effort should be made to shield the tissue from bright light during experimentation.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.